Preventive Services







EXCLUSIVE

Our preventive services include a comprehensive test to screen for diabetes, metabolic syndrome, and related chronic conditions by evaluating vascular health, autonomic nervous system function, and neuropathy. Metabolic Syndrome, a cluster of conditions increasing the risk of cardiovascular disease and diabetes, often involves vascular and autonomic dysfunction. Utilizing non-invasive TM-Flow and ETF device, we provide advanced diagnostics for early detection of risks such as peripheral arterial disease, autonomic dysfunction, and sensory loss. These tools empower providers in Primary Care, Endocrinology, Cardiology, and Podiatry to identify and manage chronic conditions effectively. 

📈 DM-Flow (4-in-1)

19:01 Minutes

Note: 15-second audio delay after pressing play.

The TM-Flow + ETF devices are effective tools for early detection, risk stratification, and monitoring of chronic diseases, making it a valuable addition in any clinical setting.

Galvanic Skin Response Test & Bioimpedance Analysis

Bleeding-edge Photoplethysmography

Ankle Brachial Index & Volume Plethysmography

Vibroception of Sensory Nerves to Stimuli

The TM-Flow with the Electronic Tuning Fork (ETF)

The TM-Flow is a state-of-the-art diagnostic system designed to revolutionize patient care by providing a comprehensive and integrated approach to health assessments. Composed of five (5) assessments, the platform offers a seamless blend of cutting-edge technology and clinical precision, enabling healthcare providers to assess and monitor critical health parameters efficiently and effectively. 


All of the assessments work together to deliver a holistic view of a patient’s health, focusing on vascular function, autonomic nervous system performance, and other vital metrics, ensuring that no aspect of patient care is overlooked. This innovative system empowers clinicians to detect early signs of chronic conditions, track disease progression, and implement preventive strategies tailored to each patient, ultimately enhancing outcomes and supporting value-based care initiatives.



Note: The 128 Hz frequency is the recognized standard in the U.S. for testing peripheral neuropathy, particularly for evaluating vibration perception in large fiber nerve function. Widely endorsed by organizations such as the American Diabetes Association (ADA), CDC, and CMS guidelines

Simply Better